Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Miltefosine and Antimony for Cutaneous Leishmaniasis in Bolivia
NCT00537953Phase 2Unknown
- Sponsor
- Centro de Investigaciones Bioclínicas de la Fundación Fader
- Modality
- DNA Intercalators/Alkylators, Covalent Small Molecules, Classical Binding Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of miltefosine, meglumine antimoniate in cutaneous leishmaniasis (CL), sponsored by Centro de Investigaciones Bioclínicas de la Fundación Fader. Status: unknown.
02
Drugs
miltefosinemeglumine antimoniate
03
Conditions
cutaneous leishmaniasis (CL)
Beyond the preview
Go deeper on NCT00537953.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00537953.